You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dulaglutide

Showing 26 - 50 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in China (Dulaglutide, Placebo, Insulin Glargine)

Completed
  • Type 2 Diabetes Mellitus
  • Dulaglutide
  • +2 more
  • Hefei, Anhui, China
  • +26 more
May 16, 2022

Diabetes, Type 2 Trial in Neuss (LY3532226, Placebo, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Neuss, Germany
    Profil Institut für Stoffwechselforschung
Jun 30, 2022

Adult Subjects With Type1Diabetes and Insulin Microsecretion Trial in France (Dulaglutide, Placebo)

Completed
  • Adult Subjects With Type1Diabetes and Insulin Microsecretion
  • Dulaglutide
  • Placebo
  • La Tronche, France
  • +6 more
Jul 7, 2021

Healthy, Type 2 Diabetes Trial in Neuss, Mainz (LY3457263, Dulaglutide, Placebo)

Completed
  • Healthy
  • Type 2 Diabetes
  • Neuss, Nordrhein-Westfalen, Germany
  • +1 more
Jan 10, 2022

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Dulaglutide
  • Placebo
  • Birmingham, Alabama
  • +60 more
Jun 7, 2022

Type 2 Diabetes Trial in Worldwide (Efpeglenatide, Dulaglutide, Background therapy Metformin)

Terminated
Has Results
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +44 more
Oct 28, 2021

Type 2 Diabetes Trial in Beijing (IBI362, Placebo, Dulaglutide)

Completed
  • Type 2 Diabetes
  • Beijing, China
    China Japan Friendship Hospital
Jul 21, 2021

Glucose Intolerance, Overweight and Obesity, Drug Effect Trial in Houston (Dulaglutide, Cyanocobalamin)

Recruiting
  • Glucose Intolerance
  • +3 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 2, 2021

Diabetes, Diabetes, Type 2 Trial in Japan (Semaglutide, Dulaglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Adachi-ku, Tokyo, Japan
  • +33 more
Feb 11, 2021

Type 2 Diabetes Trial in Worldwide (LY3502970, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Anaheim, California
  • +43 more
Jun 21, 2022

Diabetes, Type 2 Trial in United States (LY3437943, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +3 more
Jan 18, 2021

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type 2 Diabetes Trial in Puerto Rico, United States (LY3437943, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +42 more
Feb 18, 2022

Diabetes, Type 2 Trial in Guadalajara (Exenatide LAR, Dulaglutide)

Unknown status
  • Diabetes Mellitus, Type 2
  • Exenatide LAR
  • Dulaglutide
  • Guadalajara, Jalisco, Mexico
    Instituto de terapeutica Experimental y Clinica. Centro universi
Mar 24, 2020

Non Alcoholic Fatty Liver Disease, Type2 Diabetes Trial in Gurgaon (Dulaglutide)

Completed
  • Non Alcoholic Fatty Liver Disease
  • Type2 Diabetes Mellitus
  • Dulaglutide
  • Gurgaon, Haryana, India
    Division Of Endocrinology & Diabetes, Medanta The Medicity
Feb 19, 2020

Diabetes, Type 2 Trial in United States (Dulaglutide Pen, Semaglutide Pen)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dulaglutide Pen
  • Semaglutide Pen
  • Fresno, California
  • +13 more
Apr 10, 2020

Type 2 Diabetes Trial in Fresno (GLP1 receptor agonist, basal insulin, SGLT2 inhibitor)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • GLP1 receptor agonist
  • +3 more
  • Fresno, California
    UCSF Fresno
Oct 20, 2020

Semaglutide vs Dulaglutide on Epicardial Adipose Tissue

Completed
  • Epicardial Fat
    • Miami, Florida
      University of Miami
    Dec 12, 2019

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Birmingham, Alabama
    • +646 more
    Jan 18, 2023

    Healthy Trial in Dallas (Dulaglutide (Reference), Dulaglutide (Test))

    Completed
    Has Results
    • Healthy
    • Dulaglutide (Reference)
    • Dulaglutide (Test)
    • Dallas, Texas
      Covance Dallas
    Jul 26, 2019

    Type 2 Diabetes Trial in Fukuoka (Dulaglutide, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes
    • Dulaglutide
    • Placebo
    • Fukuoka, Japan
      For additional information regarding investigative sites for thi
    Aug 28, 2019

    Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

    Recruiting
    • Diabetes
    • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
    • Nanjing, China
      Nanjing First Hospital, Nanjing Medical Univesity
    Aug 6, 2023

    Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

    Recruiting
    • Type2Diabetes
    • ASCVD
    • SGLT2 inhibitor
    • +2 more
    • New York, New York
    • +1 more
    Dec 19, 2022

    Primary Polydipsia Trial in Basel (Dulaglutide, Placebo)

    Completed
    • Primary Polydipsia
    • Dulaglutide
    • Placebo
    • Basel, Switzerland
      University Hospital Basel
    Jan 16, 2020

    SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS ,

    Active, not recruiting
    • Weight Loss
    • +3 more
    • GLP-1 receptor agonist
    • Culleredo, A Coruña, Spain
    • +10 more
    Jan 13, 2023